Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fractional Laser and UVB in Vitiligo
NCT02290717Withdrawn
- Sponsor
- Netherlands Institute for Pigment Disorders
- Start
- May 2015
- Primary completion
- Nov 2015
- Countries
- 1
01
Overview
Randomised, single-blind trial (3 arms), sponsored by Netherlands Institute for Pigment Disorders. Primary endpoint: Repigmentation % with sheets at 6 months. Planned start May 2015; status: withdrawn.
Beyond the preview
Go deeper on NCT02290717.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02290717.